Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD

被引：0
|
作者：
Peter Van Buren
Ruben L. Velez
Nosratola D. Vaziri
Xin J. Zhou
机构：
[1] University of Texas Southwestern Medical Center,Departments of Internal Medicine/Nephrology
[2] Dallas Nephrology Associates,Division of Nephrology and Hypertension
[3] University of California Irvine,Department of Pathology
[4] The University of Texas Southwestern Medical Center,Division of Nephrology and Hypertension
[5] University of California Irvine Medical Center,undefined
来源：
International Urology and Nephrology | 2012年 / 44卷
关键词：
Anemia; Iron; Hemodialysis; End-stage renal disease; Chronic kidney disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：499 / 507
页数：8
相关论文
共 22 条
  • [1] Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD
    Van Buren, Peter
    Velez, Ruben L.
    Vaziri, Nosratola D.
    Zhou, Xin J.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (02) : 499 - 507
  • [2] Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease
    Vaziri, Nosratola D.
    Zhou, Xin J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (04) : 1082 - 1088
  • [3] Critical appraisal of randomized controlled trials of anemia correction in patients with renal failure
    Parfrey, Patrick S.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (02) : 177 - 181
  • [4] Left Ventricular Geometry Predicts Cardiovascular Outcomes Associated with Anemia Correction in CKD
    Eckardt, Kai-Uwe
    Scherhag, Armin
    Macdougall, Iain C.
    Tsakiris, Dimitrios
    Clyne, Naomi
    Locatelli, Francesco
    Zaug, Michael F.
    Burger, Hans U.
    Drueke, Tilman B.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (12): : 2651 - 2660
  • [5] Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD Pooled Results of Three Randomized Clinical Trials
    Provenzano, Robert
    Szczech, Lynda
    Leong, Robert
    Saikali, Khalil G.
    Zhong, Ming
    Lee, Tyson T.
    Little, Dustin J.
    Houser, Mark T.
    Frison, Lars
    Houghton, John
    Neff, Thomas B.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (08): : 1190 - 1200
  • [6] Effects of Jianpi Bushen Therapy for Treatment of CKD Anemia: A Meta-Analysis of Randomized Controlled Trials
    Li, Liang
    Li, Chengyin
    Zhou, Yu
    Xu, Qi
    Wang, Zilin
    Zhu, Xiaoyun
    Ba, Yuanming
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [7] Effectiveness of Dietary Interventions to Treat Iron-Deficiency Anemia in Women: A Systematic Review of Randomized Controlled Trials
    Skolmowska, Dominika
    Glabska, Dominika
    Kolota, Aleksandra
    Guzek, Dominika
    NUTRIENTS, 2022, 14 (13)
  • [8] The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
    Macdougall, Iain C.
    Dahl, Naomi V.
    Bernard, Kristine
    Li, Zhu
    Batyky, Alka
    Strauss, William E.
    BMC NEPHROLOGY, 2017, 18
  • [9] The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
    Iain C. Macdougall
    Naomi V. Dahl
    Kristine Bernard
    Zhu Li
    Alka Batycky
    William E. Strauss
    BMC Nephrology, 18
  • [10] Intravenous Iron Therapy to Treat Anemia in Oncology: A Mapping Review of Randomized Controlled Trials
    Lim, Jayne
    Auerbach, Michael
    Maclean, Beth
    Al-Sharea, Annas
    Richards, Toby
    CURRENT ONCOLOGY, 2023, 30 (09) : 7836 - 7851
123